146 related articles for article (PubMed ID: 27303187)
1. The Effect of 0.5% Sodium Tetradecyl Sulfate on a Venous Lake Lesion.
Jung SJ; Seo YJ; Park EJ; Kim CW; Cho HJ; Kim KH; Kim KJ
Ann Dermatol; 2008 Dec; 20(4):179-83. PubMed ID: 27303187
[TBL] [Abstract][Full Text] [Related]
2. Venous Lakes of the Lips Successfully Treated With a Sclerosing Agent 1% polidocanol: analysis of 25 report cases.
Cebeci D; Karasel S; Yaşar Ş
Int J Surg Case Rep; 2021 Jan; 78():265-269. PubMed ID: 33373920
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Head and Neck Venous Malformations with Sodium Tetradecyl Sulfate.
Karimi E; Jafari M; Aghazadeh K; Sohrabpour S; Tavakolnejad F
OTO Open; 2018; 2(3):2473974X18797067. PubMed ID: 31535070
[TBL] [Abstract][Full Text] [Related]
4. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
[TBL] [Abstract][Full Text] [Related]
5. Venous lake of the lip treated with a sclerosing agent: report of two cases.
Kuo HW; Yang CH
Dermatol Surg; 2003 Apr; 29(4):425-8. PubMed ID: 12656828
[TBL] [Abstract][Full Text] [Related]
6. Utility of sodium tetradecyl sulfate sclerotherapy from benign oral vascular lesion.
Choi BE; Kim Y; Leem DH; Baek JA; Ko SO
Maxillofac Plast Reconstr Surg; 2016 Dec; 38(1):44. PubMed ID: 27995117
[TBL] [Abstract][Full Text] [Related]
7. A new venture with sclerotherapy in an oral vascular lesion.
Sitra G; Kayalvizhi EB; Sivasankari T; Vishwanath R
J Basic Clin Pharm; 2014 Dec; 6(1):40-3. PubMed ID: 25538471
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of a Low-Dose Sclerosing Agent for the Treatment of Vascular Lesions in the Tongue.
Lim T; Kim D; Lee HW; Ohe JY; Jung J
Cureus; 2023 Sep; 15(9):e45323. PubMed ID: 37849611
[TBL] [Abstract][Full Text] [Related]
9. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.
Stuart S; Barnacle AM; Smith G; Pitt M; Roebuck DJ
Radiology; 2015 Mar; 274(3):897-905. PubMed ID: 25271855
[TBL] [Abstract][Full Text] [Related]
10. A series of 33 older patients with lip venous lake treated by sclerotherapy.
Fernandes DT; Hebling E; Santos-Silva AR; Lopes MA
Int J Dermatol; 2020 Jan; 59(1):42-46. PubMed ID: 31074017
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
[TBL] [Abstract][Full Text] [Related]
13. Staged endovascular and surgical treatment of slow-flow vulvar venous malformations.
Nassiri N; O TM; Rosen RJ; Moritz J; Waner M
Am J Obstet Gynecol; 2013 May; 208(5):366.e1-6. PubMed ID: 23395642
[TBL] [Abstract][Full Text] [Related]
14. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
Khandpur S; Sharma VK
Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions.
Bajpai H; Bajpai S
J Maxillofac Oral Surg; 2012 Mar; 11(1):13-20. PubMed ID: 23449774
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.
O'Donovan JC; Donaldson JS; Morello FP; Pensler JM; Vogelzang RL; Bauer B
AJR Am J Roentgenol; 1997 Sep; 169(3):723-9. PubMed ID: 9275886
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy of craniofacial venous malformations: complications and results.
Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
[TBL] [Abstract][Full Text] [Related]
18. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
Fabi SG; Peterson JD; Goldman MP; Guiha I
Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
[TBL] [Abstract][Full Text] [Related]
19. Sclerotherapy for eyelid and anterior orbital venous-lymphatic malformation.
Razavi ME; Rajabi MT; Hassanpoor N; Mohammadi SS
J Curr Ophthalmol; 2019 Jun; 31(2):214-217. PubMed ID: 31317102
[TBL] [Abstract][Full Text] [Related]
20. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
